Xiaowei Wang

A phase Ib study of GSK3052230, an FGF ligand trap in combination with pemetrexed and cisplatin in patients with malignant pleural mesothelioma

M. Zauderer, J. Schellens, D. Fennell, 2019, Investigational New Drugs.

An open-label phase IB study to evaluate GSK3052230 in combination with paclitaxel and carboplatin, or docetaxel, in FGFR1-amplified non-small cell lung cancer.

P. Paik, E. Felip, D. Morgensztern, 2019, Lung cancer.

A phase Ib study of GSK3052230, an FGF ligand trap in combination with pemetrexed and cisplatin in patients with malignant pleural mesothelioma

S. Gadgeel, D. Morgensztern, H. Kindler, 2019, Investigational New Drugs.

Dermal Toxicity Influence of Gold Nanomaterials after Embedment in Cosmetics

Haiyuan Zhang, Chusheng Liu, Xiaowei Wang, 2022, Toxics.

Model‐based meta‐analysis of non‐small cell lung cancer with standard of care PD‐1 inhibitors and chemotherapy for early development decision making

S. Visser, Helen Zhou, Tai-Tsang Chen, 2023, CPT: pharmacometrics & systems pharmacology.